Title of article :
Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein–Barr virus activation assay
Author/Authors :
Ito، نويسنده , , Chihiro and Itoigawa، نويسنده , , Masataka and Furukawa، نويسنده , , Hiroshi and Tokuda، نويسنده , , Harukuni and Okuda، نويسنده , , Yoko and Mukainaka، نويسنده , , Teruo and Okuda، نويسنده , , Masato and Nishino، نويسنده , , Hoyoku، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1999
Abstract :
In a search for anti-tumor-promoting agents, we carried out a primary screening of twenty-nine 8-substituted and four 6-substituted derivatives of 7-methoxycoumarins isolated from plants of the Murraya and/or Citrus species (Rutaceae), examining their possible inhibitory effects on Epstein–Barr virus early antigen (EBV–EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. This investigation indicated that the prenyl (3-methyl-2-butenyl) or 2-hydroxy-3-methylbutyl (or butenyl) unit as an isoprenoid moiety at C-8 on the 7-methoxycoumarin nucleus plays an important role in the anti-tumor-promoting activity. Some of the 8-substituted 7-methoxycoumarins isolated from Murraya species, murrangatin (7), minumicrolin (10) and chloticol (18), were found to significantly inhibit EBV–EA activation, and preserved the high viability of Raji cells, suggesting that 7, 10 and 18 might be valuable anti-tumor-promoting agents.
Keywords :
8-Substituted 7-methoxycoumarins , Epstein–Barr virus activation test , Anti-tumor-promoting effect , structure-activity relationships
Journal title :
Cancer Letters
Journal title :
Cancer Letters